Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05121558 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.
Track this trial| NCT Number | NCT05121558 |
| Lead Sponsor | Dana-Farber Cancer Institute
Collaborators: National Cancer Institute (NCI) |
| Conditions | Chemotherapy-induced Peripheral Neuropathy, Nerve Pain, Neuropathy, Neuropathy, Painful, Pain, CIPN - Chemotherapy-Induced Peripheral Neuropathy, Chronic Pain |
| Enrollment | 227 participants |
| Start Date | 2021-10-29 |
| Primary Completion | 2028-09-30 (estimated) |
| Study Completion | 2028-09-30 (estimated) |
| Updated on ClinicalTrials.gov | 2026-09-22 |